How to address immunogenicity in the development of a rare disease biosimilar
Rare diseases tremendously lack affordable treatment options. Orphan drugs have been neglected
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Rare diseases tremendously lack affordable treatment options. Orphan drugs have been neglected
Rare diseases hugely need moderate treatment choices. Vagrant medications have been ignored
Precision medicine identifies the evolving field holding the promise to transform our
Biotherapeutic products are the fastest growing medicines in the pharmaceutical market. Historically
Twenty-four countries have already approved biosimilars. Some of them, like China
Adoption of biosimilars is increasingly attractive to payers around the globe due
Biotherapeutic products are the fastest growing medicines in the pharmaceutical market. Here
For authors and organisers
Find the right journal for your paper and submit your manuscript.